Curious about what else BCC's AI Reports cover?
Get complimentary access to VerticalContext Chat.
Report Highlights
This report covers the impact of AI on biomarkers market. It highlights how AI is reshaping the key industry verticals and how market players are investing in AI to gain control.
Report Includes
- An analysis of the AI impact on global market for biomarkers
- Insights of the key Use Cases for AI implementation in drug discovery and development, early disease detection and diagnostics, companion diagnostics and personalized therapy, and clinical trial optimization
- Understanding of AI adoption trends to improve biomarker identification and validation
- Coverage of AI disruption trends affecting driving discovery, validation, and clinical application innovations
- Impact analysis of AI on various stages like speeding discovery, increasing the accuracy of assessment, and improving the speed of development and regulatory approval processes
- Impact of AI on major pharmaceutical companies, diagnostics, and technology companies which are forming partnerships to capitalize on the use of AI in biomarker development
Report Scope
Artificial intelligence (AI) is changing patient care through predictive biomarker matching in precision medicine. Biomarkers reflect the biological state of tissue and help clinicians make treatment decisions. AI currently supports key components of biomarker matching: data integration and management, predictive modeling and dynamic biomarker tracking. AI-enhanced biomarker matching can transform the experience of developing therapies that enhance clinical trial success rates, improve patient outcomes and reduce healthcare expenditures across each therapeutic area in the long term.
Recent Reports
Global Market for AI In Waste Management
The global market for AI in waste management is expected to grow from $48.1 billion in 2026 and is projected to reach $85.8 billion by the end of 2031, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2026 to 2031.
State of the Artificial Intelligence Technology (AIT) Industry - 2026 Third Quarter Review
During the third quarter of 2026, artificial intelligence (AI) continued to expand across business operations as organizations moved beyond standalone applications toward broader workflow integration. Enterprises increasingly adopted AI assistants, automation platforms, agents, and industry-specific solutions to improve productivity, decision-making, customer experience, and operational efficiency. This growing adoption also accelerated investment in cloud computing, AI infrastructure, data platforms, and networking, while increasing the focus on data quality, security, governance, scalability, and measurable business outcomes.
AI Impact on 3D Printing Drugs - BCC Pulse Report
This report provides an outlook of artificial intelligence impact on the global 3D printing drugs market. It highlights major adoption trends of across the key geographic regions, and a review of market disruptions caused across several key industry verticals.
Global AI Investment Trends & Spending Outlook
This report reviews global investment in artificial intelligence (AI), covering spending on hardware, software, services, and infrastructure. It examines funding priorities across industries and regions, the role of public and private investment, and the factors influencing business spending on AI.
AI Disruption: A Global Overview
This report provides a comprehensive assessment of global AI disruption in Q3 2026 across technological, operational, customer-facing, and competitive dimensions. It examines the transition from generative AI assistants to agentic AI capable of planning, reasoning, and executing multi-step workflows. The study also covers changes in workforce structures, capital allocation, and AI governance.
Top Trending Reports
Bioinformatics: Technologies and Global Markets
The global bioinformatics market was valued at $23.5 billion in 2025 and is estimated to reach $43.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 to 2030.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Global Enterprise Artificial Intelligence (AI) Market
This study examines the global enterprise AI market across key segments such as component, software deployment, technology, organization size, end user and geography. It focuses on commercially deployed AI software, services and hardware generating revenue across industries, including new deployments and the expansion of existing AI infrastructure. The analysis also covers emerging technologies, major market trends and challenges, the competitive landscape and profiles of leading companies. Regional market trends are assessed using 2025 as the base year, with forecasts from 2026 through 2031.
Global Vaccine Adjuvants Market
This report provides an analysis of the global market for vaccine adjuvants. It focuses on the key driving trends and challenges. The study evaluates the competitive landscape, reviews key technological developments, and provides market estimates and forecasts through 2031.
Outpatient Surgical Procedures: Global Markets
The global market for outpatient surgical procedures is expected to grow from $381.9 billion in 2026 and is projected to reach $598.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2026 to 2031.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More